Browse Wiki & Semantic Web

Jump to: navigation, search
Http://dbpedia.org/resource/HT-2157
  This page has no properties.
hide properties that link here 
  No properties link to this page.
 
http://dbpedia.org/resource/HT-2157
http://dbpedia.org/ontology/abstract HT-2157 (former development code SNAP-3788HT-2157 (former development code SNAP-37889) is a drug which acts as a selective non-peptide antagonist for the receptor GAL-3, which is usually activated by the neuropeptide galanin. Blocking this receptor with HT-2157 produced increased serotonin release, as well as producing antidepressant and anxiolytic effects in animal studies, and it was also being researched for treatment of cognitive dysfunction. All human clinical trials were terminated due to safety concerns however, and new GAL-3 antagonists are now being sought instead. antagonists are now being sought instead.
http://dbpedia.org/ontology/casNumber 303149-14-6
http://dbpedia.org/ontology/fdaUniiCode J4DRJ9BFS1
http://dbpedia.org/ontology/pubchem 1471834
http://dbpedia.org/ontology/thumbnail http://commons.wikimedia.org/wiki/Special:FilePath/HT-2157_formula_skeletal.svg?width=300 +
http://dbpedia.org/ontology/wikiPageID 44748690
http://dbpedia.org/ontology/wikiPageLength 2867
http://dbpedia.org/ontology/wikiPageRevisionID 1073190181
http://dbpedia.org/ontology/wikiPageWikiLink http://dbpedia.org/resource/Serotonin + , http://dbpedia.org/resource/Anxiolytic + , http://dbpedia.org/resource/Category:Receptor_antagonists + , http://dbpedia.org/resource/Galanin + , http://dbpedia.org/resource/Neuropeptide + , http://dbpedia.org/resource/Category:Abandoned_drugs + , http://dbpedia.org/resource/Cognitive_dysfunction + , http://dbpedia.org/resource/Category:Trifluoromethyl_compounds + , http://dbpedia.org/resource/Antidepressant + , http://dbpedia.org/resource/Galanin_receptor_3 + , http://dbpedia.org/resource/Category:Peptides + , http://dbpedia.org/resource/Receptor_antagonist +
http://dbpedia.org/property/alt Space-filling model , Structural formula
http://dbpedia.org/property/atcPrefix none
http://dbpedia.org/property/c 21
http://dbpedia.org/property/casNumber 303149
http://dbpedia.org/property/chemspiderid 1213983
http://dbpedia.org/property/f 3
http://dbpedia.org/property/h 13
http://dbpedia.org/property/image HT-2157 molecule spacefill.png
http://dbpedia.org/property/iupacName 1
http://dbpedia.org/property/iupharLigand 6126
http://dbpedia.org/property/n 2
http://dbpedia.org/property/o 1
http://dbpedia.org/property/pubchem 1471834
http://dbpedia.org/property/smiles c14ccccc4ncc1=N\ccccc2CF
http://dbpedia.org/property/stdinchi 1
http://dbpedia.org/property/stdinchikey TXCGMRVPXUBHAL-NCELDCMTSA-N
http://dbpedia.org/property/unii J4DRJ9BFS1
http://dbpedia.org/property/width 190 , 210
http://dbpedia.org/property/wikiPageUsesTemplate http://dbpedia.org/resource/Template:Drugbox + , http://dbpedia.org/resource/Template:Reflist + , http://dbpedia.org/resource/Template:Fdacite + , http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
http://purl.org/dc/terms/subject http://dbpedia.org/resource/Category:Receptor_antagonists + , http://dbpedia.org/resource/Category:Peptides + , http://dbpedia.org/resource/Category:Trifluoromethyl_compounds + , http://dbpedia.org/resource/Category:Abandoned_drugs +
http://purl.org/linguistics/gold/hypernym http://dbpedia.org/resource/Drug +
http://www.w3.org/ns/prov#wasDerivedFrom http://en.wikipedia.org/wiki/HT-2157?oldid=1073190181&ns=0 +
http://xmlns.com/foaf/0.1/depiction http://commons.wikimedia.org/wiki/Special:FilePath/HT-2157_formula_skeletal.svg + , http://commons.wikimedia.org/wiki/Special:FilePath/HT-2157_molecule_spacefill.png +
http://xmlns.com/foaf/0.1/isPrimaryTopicOf http://en.wikipedia.org/wiki/HT-2157 +
owl:sameAs https://global.dbpedia.org/id/sp36 + , http://vi.dbpedia.org/resource/HT-2157 + , http://rdf.freebase.com/ns/m.012hdy1p + , http://yago-knowledge.org/resource/HT-2157 + , http://www.wikidata.org/entity/Q19597525 + , http://dbpedia.org/resource/HT-2157 +
rdf:type http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject + , http://dbpedia.org/ontology/ChemicalSubstance + , http://dbpedia.org/ontology/Drug + , http://www.wikidata.org/entity/Q8386 +
rdfs:comment HT-2157 (former development code SNAP-3788HT-2157 (former development code SNAP-37889) is a drug which acts as a selective non-peptide antagonist for the receptor GAL-3, which is usually activated by the neuropeptide galanin. Blocking this receptor with HT-2157 produced increased serotonin release, as well as producing antidepressant and anxiolytic effects in animal studies, and it was also being researched for treatment of cognitive dysfunction. All human clinical trials were terminated due to safety concerns however, and new GAL-3 antagonists are now being sought instead. antagonists are now being sought instead.
rdfs:label HT-2157
hide properties that link here 
http://dbpedia.org/resource/Snap + , http://dbpedia.org/resource/Signaling_peptide_receptor + , http://dbpedia.org/resource/List_of_signaling_peptide/protein_receptor_modulators + , http://dbpedia.org/resource/SNAP-37889 + http://dbpedia.org/ontology/wikiPageWikiLink
http://en.wikipedia.org/wiki/HT-2157 + http://xmlns.com/foaf/0.1/primaryTopic
http://dbpedia.org/resource/HT-2157 + owl:sameAs
 

 

Enter the name of the page to start semantic browsing from.